Cardiac Rehabilitation in Patients With Refractory Angina
1 other identifier
interventional
72
1 country
1
Brief Summary
The purpose of this study is to evaluate the safety and feasibility of cardiovascular rehabilitation in Patients with refractory angina, evaluate the effect of cardiovascular rehabilitation in patients with angina Refractory, by maximal oxygen consumption (VO2max) and global myocardial ischemic load by Stress Echocardiography; To evaluate the presence of myocardial injury, caused by physical stress, through ultra-sensitive troponin after sessions of aerobic physical activity, evaluating the behavior during the training period; To evaluate the effect of rehabilitation on the modulation of sympathetic activity and inflammation, muscular blood flow and lipid metabolism; To evaluate of the effect of rehabilitation on ventricular function through Stress echocardiography; Detection of ischemic episodes and arrhythmias identified during the Rehabilitation sessions through external cardiac monitoring (telemetry); Evaluate the quality of life assessment through the SF-36 questionnaire, Canadian Cardiovascular Society, the number of symptomatic episodes of ischemia, daily sublingual nitrate intake.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 5, 2017
CompletedFirst Posted
Study publicly available on registry
July 17, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2022
CompletedFebruary 11, 2022
March 1, 2020
4.6 years
June 5, 2017
February 10, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Cardiovascular rehabilitation in patients with refractory angina is safe;
Evaluated number of patients who have any kind of cardiovascular event during rehabilitation, as well as number of sore throat during the sessions.
3 months of rehabilitation
Cardiovascular rehabilitation in patients with refractory angina is efficient;
Evaluated number of sore throat during the sessions.
3 months of rehabilitation
Improve the maximal oxygen consumption
Improvement of Maximal oxygen uptake (VO2max)
3 months of rehabilitation
Improve the global myocardial ischemic load
Reduction of myocardial ischemia, evidenced by improvement of the standard by effort echocardiography
3 months of rehabilitation
Secondary Outcomes (8)
Reduction of myocardial injury caused by physical stress
3 months of rehabilitation
Rehabilitation will modulate sympathetic activity
3 months of rehabilitation
Improvement of ventricular function
3 months of rehabilitation
Improvement of the quality of life
3 months of rehabilitation
Rehabilitation will increase muscle blood flow
3 months of rehabilitation
- +3 more secondary outcomes
Study Arms (4)
Clinical treatment physical training
EXPERIMENTALPatients with optimized clinical treatment group that will do physical training for 12 weeks. They will do the tests in moment 1 and after 3 mounths. The intervention is the Cardiac Rehabilitation.
Optimized clinical treatment
NO INTERVENTIONPatients with optimized clinical treatment group that will not do physical training.They will do the tests in moment 1 and after 3 mounths.
Coronary insufficiency without angina
NO INTERVENTIONGroup with coronary insufficiency without angina and will not do physical training. They will do the tests only one moment.
Normal healthy subjects
NO INTERVENTIONGroup normal healthy subjects, without coronary injuries, diabetes, hypertension and another chronic disease. These group have be sedentary and will not do physical training. They will do the tests only one moment.
Interventions
The physical training program will start shortly after the initial exams have been completed. The physical training protocol will consist of a 12-week duration, with a frequency of 3 weekly sessions of 60 minutes duration each. The intensity will be prescribed from the echocardiogram with effort and cardiopulmonary test. All sessions will be monitored by telemetry and will be distributed as follows: * 5 minutes warm up * 30 to 40 minutes of aerobic exercise (treadmill). The training intensity will be prescribed individually, based on the results of the test results; * 10 minutes of localized exercises; * 5 minutes of relaxation.
Eligibility Criteria
You may qualify if:
- Stable angina functional class II to IV according to the classification of Canadian Cardiovascular Society (CCS) 39, or limiting angina in Perception of the patient;
- Documented myocardial ischemia by imaging method;
- Patients not eligible for myocardial revascularization procedures surgical conventional, due to the unfavorable anatomy;
- Signature of the Free and Informed Consent Form.
You may not qualify if:
- Patients with definitive pacemaker or implantable cardioverter defibrillator (ICD);
- Patients with non-sinus heart rhythm;
- Patients with complete intraventricular block;
- Acute coronary syndrome (myocardial infarction or unstable angina) or previous procedures for myocardial revascularization (angioplasty / surgery) less than 3 months;
- Functional impossibility (orthopedic, rheumatic, neurological, or otherwise) or social for participation in the Rehabilitation Program;
- Classification of risk for American Heart Association class D physical training (unstable ischemia, stenosis or severe or symptomatic valve insufficiency, congenital heart disease, decompensated heart failure, uncontrolled arrhythmias and other conditions that may be aggravated by exercise).
- Group 3
- Patients with coronary insufficiency without angina;
- Signature of the Free and Informed Consent Form.
- Group 4
- Signature of the Free and Informed Consent Form;
- Healthy;
- Non-smokers;
- Sedentary
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hospital Israelita Albert Einsteinlead
- Fundação de Amparo à Pesquisa do Estado de São Paulocollaborator
- Instituto do Coracaocollaborator
Study Sites (1)
Instituto Israelita de Ensino e Pesquisa Albert Einstein 's (IIEP)
São Paulo, 05652-000, Brazil
Related Publications (1)
de Assumpcao CRA, do Prado DML, Jordao CP, Dourado LOC, Vieira MLC, Montenegro CGSP, Negrao CE, Gowdak LHW, De Matos LDNJ. Cardiopulmonary exercise test in patients with refractory angina: functional and ischemic evaluation. Clinics (Sao Paulo). 2022 Feb 5;77:100003. doi: 10.1016/j.clinsp.2021.100003. eCollection 2022.
PMID: 35134662DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luciana Janot de Matos, Dra
Hospital Israelita Albert Einstein
- PRINCIPAL INVESTIGATOR
Luciana Janot de Matos, Dra
InCor Heart Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 5, 2017
First Posted
July 17, 2017
Study Start
January 1, 2016
Primary Completion
July 28, 2020
Study Completion
February 1, 2022
Last Updated
February 11, 2022
Record last verified: 2020-03
Data Sharing
- IPD Sharing
- Will not share